CLINICAL-SIGNIFICANCE OF BETA-LACTAMASE INDUCTION AND STABLE DEREPRESSION IN GRAM-NEGATIVE RODS

被引:210
作者
LIVERMORE, DM
机构
关键词
D O I
10.1007/BF02013107
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:439 / 445
页数:7
相关论文
共 40 条
[11]   PSEUDOMONAS-AERUGINOSA BETA-LACTAMASE AS A DEFENSE AGAINST AZLOCILLIN, MEZLOCILLIN AND PIPERACILLIN [J].
JACOBS, JY ;
LIVERMORE, DM ;
DAVY, KWM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (03) :221-229
[12]   ANTIBACTERIAL ANTAGONISM OF BETA-LACTAM ANTIBIOTICS IN EXPERIMENTAL INFECTIONS [J].
KASAI, K .
CHEMOTHERAPY, 1986, 32 (02) :148-158
[13]  
KIRKPATRICK B, 1986, LANCET, V1, P802
[14]   REGULATORY COMPONENTS IN CITROBACTER-FREUNDII AMPC BETA-LACTAMASE INDUCTION [J].
LINDBERG, F ;
WESTMAN, L ;
NORMARK, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (14) :4620-4624
[15]  
LINDBERG F, 1986, REV INFECTIOUS DIS S, V8, P292
[17]   DO BETA-LACTAMASES TRAP CEPHALOSPORINS [J].
LIVERMORE, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (05) :511-514
[18]  
LIVERMORE DM, 1986, LANCET, V1, P450
[20]  
LIVERMORE DM, 1985, CHEMIOTERAPIA, V4, P28